FluGen
WI - MadisonBiotechnology
Focus: FluGen is a Wisconsin-based biotech company focused on developing novel influenza vaccines and adjuvants using proprietary M2SR technology. The company operates in the infectious disease vaccine space with an early-stage pipeline.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Open Jobs
0
About FluGen
AI assessmentNot HiringNo open roles listed right now. Follow FluGen to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from FluGen's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
FLUGEN 101.2 device
InfluenzaClinical Trials (1)
NCT01767337Intracutaneous Delivery of Varied Dose Volumes of Saline
N/AHelp build intelligence for FluGen
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.